disulfiram has been researched along with Porphyrias in 2 studies
Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BOM, F | 1 |
| Cavanagh, JB | 1 |
1 review available for disulfiram and Porphyrias
| Article | Year |
|---|---|
Peripheral neuropathy caused by chemical agents.
Topics: Acrylamides; Animals; Arsenic; Axons; Carbon Disulfide; Disulfiram; Humans; In Vitro Techniques; Iso | 1973 |
1 other study available for disulfiram and Porphyrias
| Article | Year |
|---|---|
[Late cutaneous porphyria with neuropsychiatric complications possible due to antabuse therapy].
Topics: Administration, Cutaneous; Disulfiram; Humans; Mental Disorders; Porphyrias; Psychotic Disorders | 1952 |